Log In
BCIQ
Print this Print this
 

miR-7-5p (microRNA-7-5p)

  Manage Alerts
Collapse Summary General Information
Company MiReven Pty. Ltd.
DescriptionMiRNA targeting insulin receptor substrate 2 (IRS2), an activator of protein kinase B (PKB; PKBA; AKT; AKT1)
Molecular Target Insulin receptor substrate 2 (IRS2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat metastatic melanoma
Regulatory Designation
PartnerSilence Therapeutics plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/27/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today